Researchers at the University of California, Irvine and New York's Columbia University have embedded transistors in a soft, ...
The $90m will be used to launch the second of two pivotal trials examining the company’s therapy for patients living with ...
Gore & Associates announced the recent CE Mark approval of a lower-profile Gore Viabahn VBX balloon expandable endoprosthes ...
The ASTRAL trial, the largest randomized trial of renal artery stenting, failed to demonstrate any benefit of renal stenting over medical therapy. [20] This was a multicenter randomized trial that ...
procedures to widen narrowed arteries, thereby improving blood flow and preventing plaque buildup and restenosis. The market growth is driven by advancements in biocompatible stent technologies and ...
However, traditional metal stents may cause restenosis - a re-narrowing of the artery - due to excessive smooth muscle cell proliferation one month after implantation. Drug-eluting stents are ...
Department of Chemical Engineering and Analytical Chemistry, Institute for Research on Nutrition and Food Safety (INSA·UB), University of Barcelona, 08028 Barcelona, Spain ...
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed to replace a patient’s damaged artery following traumatic injuries ...
The management of CLI with the use of drug-eluting stents is likely to be significantly altered by the results of ongoing research. If the improved angiographic results seen with the use of DES do ...